Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1972 1
1973 1
1975 2
1976 1
1977 1
1981 1
1983 1
1984 2
1985 1
1986 1
1987 1
1988 1
1991 1
1997 1
1998 3
2000 5
2001 7
2002 4
2003 4
2004 3
2005 4
2006 2
2007 8
2008 9
2009 8
2010 7
2011 4
2012 5
2013 6
2014 4
2015 6
2016 2
2017 5
2018 5
2019 9
2020 6
2021 9
2022 3
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

139 results

Results by year

Filters applied: . Clear all
Page 1
Editorial: Advancements in computational studies of drug toxicity.
Flynn NR, Miller GP, Swamidass SJ. Flynn NR, et al. Among authors: miller gp. Front Pharmacol. 2023 Jun 6;14:1230409. doi: 10.3389/fphar.2023.1230409. eCollection 2023. Front Pharmacol. 2023. PMID: 37346295 Free PMC article. No abstract available.
Bioactivation and reactivity research advances - 2021 year in review.
Jackson KD, Argikar UA, Cho S, Crouch RD, Driscoll JP, Heck CJS, King L, Maw HH, Miller GP, Seneviratne HK, Wang S, Wei C, Zhang D, Khojasteh SC. Jackson KD, et al. Among authors: miller gp. Drug Metab Rev. 2022 Aug;54(3):246-281. doi: 10.1080/03602532.2022.2097254. Epub 2022 Aug 5. Drug Metab Rev. 2022. PMID: 35876116 Free PMC article. Review.
Biotransformation research advances - 2022 year in review.
Khojasteh SC, Argikar UA, Cheruzel L, Cho S, Crouch RD, Dhaware D, Heck CJS, Johnson KM, Kalgutkar AS, King L, Liu J, Ma B, Maw H, Miller GP, Seneviratne HK, Takahashi RH, Wang S, Wei C, Jackson KD. Khojasteh SC, et al. Among authors: miller gp. Drug Metab Rev. 2023 Nov;55(4):301-342. doi: 10.1080/03602532.2023.2262161. Epub 2023 Oct 28. Drug Metab Rev. 2023. PMID: 37737116 Review.
Bioactivation and reactivity research advances - 2022 year in review‡.
Wang S, Argikar UA, Cheruzel L, Cho S, Crouch RD, Dhaware D, Heck CJS, Johnson KM, Kalgutkar AS, King L, Liu J, Ma B, Maw H, Miller GP, Seneviratne HK, Takahashi RH, Wei C, Khojasteh SC. Wang S, et al. Among authors: miller gp. Drug Metab Rev. 2023 Nov;55(4):267-300. doi: 10.1080/03602532.2023.2244193. Epub 2023 Aug 22. Drug Metab Rev. 2023. PMID: 37608698 Review.
Biotransformation and bioactivation reactions - 2018 literature highlights.
Khojasteh SC, Bumpus NN, Driscoll JP, Miller GP, Mitra K, Rietjens IMCM, Zhang D. Khojasteh SC, et al. Among authors: miller gp. Drug Metab Rev. 2019 May;51(2):121-161. doi: 10.1080/03602532.2019.1615937. Epub 2019 Aug 6. Drug Metab Rev. 2019. PMID: 31170851 Review.
2,3-Bis(bromo-meth-yl)-1,4-diphenyl-benzene.
Briggs JB, Jazdzyk MD, Miller GP. Briggs JB, et al. Among authors: miller gp. Acta Crystallogr Sect E Struct Rep Online. 2009 Dec 4;66(Pt 1):o12. doi: 10.1107/S1600536809050764. Acta Crystallogr Sect E Struct Rep Online. 2009. PMID: 21580009 Free PMC article.
139 results